Literature DB >> 4233003

[Inhibition of monoamine oxidase by bacteriostatically active nitrofuran derivatives].

D Palm, U Magnus, H Grobecker, J Jonsson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 4233003

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol


× No keyword cloud information.
  8 in total

1.  [Damage to the nervous system due to nitrofurans in the rat].

Authors:  G W Klinghardt
Journal:  Acta Neuropathol       Date:  1967-08-02       Impact factor: 17.088

2.  Rates of recovery of irreversibly inhibited monoamine oxidases: a measure of enzyme protein turnover.

Authors:  G Planz; K Quiring; D Palm
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1972       Impact factor: 3.000

3.  Effect of 6-hydroxydopamine on oxidative phosphorylation and on monoamine oxidase activity.

Authors:  K Wagner; U Trendelenburg
Journal:  Naunyn Schmiedebergs Arch Pharmakol       Date:  1971

4.  Inhibition of amine oxidases by nitrofuran derivatives: possible structure-activity relations and criteria of irreversibility.

Authors:  K Quiring; D Palm
Journal:  Naunyn Schmiedebergs Arch Pharmakol       Date:  1970

5.  [Inhibition of monoamine oxidase and diamine oxidase by furazolidone (Furoxon). Pharmacologic and biochemical studies in man].

Authors:  D Palm; U Magnus
Journal:  Klin Wochenschr       Date:  1968-07-01

Review 6.  Some pharmacological and toxicological properties of furazolidone.

Authors:  B H Ali
Journal:  Vet Res Commun       Date:  1983-01       Impact factor: 2.459

7.  Safety of furazolidone-containing regimen in Helicobacter pylori infection: a systematic review and meta-analysis.

Authors:  Chao-Ran Ji; Jing Liu; Yue-Yue Li; Chuan-Guo Guo; Jun-Yan Qu; Yan Zhang; Xiuli Zuo
Journal:  BMJ Open       Date:  2020-10-19       Impact factor: 2.692

8.  Furazolidone and serotonin syndrome: is there any association?

Authors:  Petros N Karamanakos
Journal:  Clinics (Sao Paulo)       Date:  2008-08       Impact factor: 2.365

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.